Address
Email address
Phone number
https://firstpharma.eeFirst PharmaYour pharma business in Estonia begins here. We are an enthusiastic team with the background of various fields of healthcare.
Name
First Pharma OÜ
Registry code
11941125
VAT number
EE101394327
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
14.05.2010 (14)
Financial year
01.01-31.12
Capital
2 589.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
5 240 425 €
253 201 €
5%
2 663 €
(estimate is approximate)
256 049 €
7
Submitted
No tax arrears
99%
28%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Lauri Leemet 30.03.1975 (49) | 33% - 863.00 EUR | Board member | Direct ownership | Founder |
| Ain Kaljurand 07.08.1964 (60) | 33% - 863.00 EUR | Board member | Direct ownership | |
| Pharma Trade OÜ 14003284 | 33% - 863.00 EUR | - | - | |
| Ivari Saar 04.05.1985 (39) | - | - | - | Founder |
| Tarmo Laanetu 12.12.1974 (49) | - | - | - | Founder |
| 2019 30.06.2020 | 2020 30.06.2021 | 2021 17.08.2022 | 2022 30.06.2023 | 2023 26.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 3 107 916 € | 4 595 381 € | 4 239 209 € | 5 138 231 € | 5 240 425 € |
| Net profit (loss) for the period | 29 848 € | 147 290 € | 112 941 € | 177 850 € | 253 201 € |
| Profit Margin | 1% | 3% | 3% | 3% | 5% |
| Current Assets | 464 818 € | 618 637 € | 655 311 € | 794 476 € | 886 964 € |
| Fixed Assets | - | 8 680 € | 52 468 € | 40 248 € | 28 028 € |
| Total Assets | 464 818 € | 627 317 € | 707 779 € | 834 724 € | 914 992 € |
| Current Liabilities | 360 053 € | 469 448 € | 528 680 € | 645 852 € | 658 943 € |
| Non Current Liabilities | 0 € | 0 € | 31 721 € | 8 174 € | 0 € |
| Total Liabilities | - | - | 560 401 € | 654 026 € | - |
| Share Capital | - | - | - | - | - |
| Equity | 104 765 € | 157 869 € | 147 378 € | 180 698 € | 256 049 € |
| Employees | 5 | 6 | 7 | 7 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 2 355 018.66 € | 47 704.54 € | 39 729.14 € | 7 |
| 2023 Q4 | 2 414 290.07 € | 42 557.79 € | 33 731.49 € | 7 |
| 2023 Q3 | 2 527 515.32 € | 7 616.62 € | 31 790.54 € | 7 |
| 2023 Q2 | 1 685 677.87 € | 20 540.63 € | 27 534.85 € | 7 |
| 2023 Q1 | 1 823 494.57 € | 27 372.4 € | 30 872.45 € | 7 |
| 2022 Q4 | 2 332 815.28 € | 276.25 € | 27 962.71 € | 7 |
| 2022 Q3 | 2 314 355.72 € | 23 120.59 € | 32 659.59 € | 7 |
| 2022 Q2 | 2 161 874.42 € | 42 368.66 € | 31 507.98 € | 7 |
| 2022 Q1 | 1 723 750.81 € | 7 932.81 € | 28 524.35 € | 7 |
| 2021 Q4 | 1 528 906.61 € | 33 055.61 € | 27 952.31 € | 7 |
| 2021 Q3 | 1 226 697.98 € | 30 217.69 € | 26 656.24 € | 7 |
| 2021 Q2 | 1 435 831.72 € | - | 26 230.15 € | 6 |
| 2021 Q1 | 1 338 406.33 € | 30 701.33 € | 25 046.77 € | 6 |
| 2020 Q4 | 2 165 945.08 € | 28 109.59 € | 31 359.7 € | 6 |
| 2020 Q3 | 1 359 999.85 € | 22 814.22 € | 23 466.51 € | 6 |
| 2020 Q2 | 1 593 612.82 € | 13 319.81 € | 31 226.91 € | 6 |
| 2020 Q1 | 1 505 865.12 € | - | 23 493.08 € | 7 |
